EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Leishmania Extracellular Vesicles as a Preventive Vaccine Platform Against Leishmaniasis

Ismail Cem Yilmaz, Ibrahim Tokmak, Muzaffer Yildirim, Tugce Canavar Yildirim, Elif Sena Ozkoc, Irem Evcili, Emre Mert Ipekoglu, İhsan Cihan Ayanoglu, Emre Dunuroglu, Dicle Caliskan, Harun Onler, Zeynep Arzum, Ceren Ulker, Olcay Mert, Ridvan Orkut, Ibrahim Oguzhan Tarman, Ulku Guler, Bekir Salih, Volkan Yazar, Gokcen Ozgun, Serap Birincioglu, Ahmet Ozbilgin, Bilgi Gungor, Ihsan Gursel, Mayda Gursel

Journal of Extracellular Vesicles · 2026-04 · 15 (4)

DOI: 10.1002/jev2.70252 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Leishmaniasis, caused by Leishmania spp., is one of the most neglected tropical diseases and poses a serious threat to public health, accounting for at least one million new cases each year. There is no available human vaccine. In this study, we explored the potential of Leishmania extracellular vesicles (EVs) as a vaccine platform, employing a production and purification method to aid clinical translation and facilitate vaccine development in an affordable setting. Immunization with Leishmania major and Leishmania infantum EVs elicited robust humoral and cellular immune responses, providing protection and cross‐protection against live parasite challenge in selected susceptible BALB/c mouse infection models. Inclusion of specific adjuvants significantly influenced vaccination outcome, highlighting the importance of adjuvant choice in determining effective protection versus susceptibility. Our findings demonstrate the potential of EVs not only for the prevention of leishmaniasis but also for broader applications in combating other protozoan infections.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →